• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-糖蛋白介导的 [(18)F]MPPF 转运的差异:在小鼠和非人灵长类动物中的药代动力学研究。

Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates.

机构信息

CEA, I2BM, Service Hospitalier Frédéric Joliot, Orsay 91401, France.

出版信息

Pharm Res. 2012 Sep;29(9):2468-76. doi: 10.1007/s11095-012-0776-7. Epub 2012 May 30.

DOI:10.1007/s11095-012-0776-7
PMID:22644589
Abstract

PURPOSE

Several in vivo studies have found that the 5-HT(1A) PET radioligand (18)F-MPPF is a substrate of rodent P-glycoprotein (P-gp). However, in vitro assays suggest that MPPF is not a substrate of human P-gp. We have now tested the influence of inhibiting P-gp on the brain kinetics of (18)F-MPPF in mice and non-human primates.

METHODS

We measured the peripheral kinetics (arterial input function, metabolism, free fraction in plasma (f(P))) during (18)F-MPPF brain PET scanning in baboons with or without cyclosporine A (CsA) infusion. We measured (3)H-MPPF transport at the mouse BBB using in situ brain perfusion in P-gp/Bcrp deficient mice and after inhibiting P-gp with PSC833.

RESULTS

There was an unexpected 1.9-fold increase in brain area under the curve in CsA-treated baboons (n = 4), with no change in radiometabolite-corrected arterial input. However, total volume of distribution corrected for f(P) (V(T)/f(P)) remained unchanged. In situ brain perfusion showed that P-gp restricted the permeability of the mouse BBB to (3)H-MPPF while Bcrp did not.

CONCLUSION

These and previous in vitro results suggest that P-gp may not influence the permeability of human BBB to (18)F-MPPF. However, CsA treatment increased (18)F-MPPF free fraction, which is responsible for a misleading, P-gp unrelated enhanced brain uptake.

摘要

目的

几项体内研究发现,5-HT(1A) PET 放射性配体(18)F-MPPF 是啮齿动物 P 糖蛋白(P-gp)的底物。然而,体外测定表明 MPPF 不是人 P-gp 的底物。我们现在已经测试了抑制 P-gp 对(18)F-MPPF 在小鼠和非人类灵长类动物脑中动力学的影响。

方法

我们在给予环孢菌素 A(CsA)输注或不给予 CsA 输注的狒狒中,测量(18)F-MPPF 脑 PET 扫描期间的外周动力学(动脉输入函数、代谢、血浆中游离分数(f(P)))。我们使用 P-gp/Bcrp 缺陷型小鼠的原位脑灌注和 PSC833 抑制 P-gp 来测量(3)H-MPPF 在小鼠 BBB 中的转运。

结果

在 CsA 处理的狒狒(n = 4)中,脑区曲线下面积出乎意料地增加了 1.9 倍,放射性代谢产物校正的动脉输入没有变化。然而,校正 f(P)的总分布容积(V(T)/f(P))保持不变。原位脑灌注表明 P-gp 限制了(3)H-MPPF 通过小鼠 BBB 的通透性,而 Bcrp 则没有。

结论

这些和以前的体外结果表明,P-gp 可能不会影响(18)F-MPPF 通过人 BBB 的通透性。然而,CsA 处理增加了(18)F-MPPF 游离分数,这导致了一种误导性的、与 P-gp 无关的增强的脑摄取。

相似文献

1
Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates.P-糖蛋白介导的 [(18)F]MPPF 转运的差异:在小鼠和非人灵长类动物中的药代动力学研究。
Pharm Res. 2012 Sep;29(9):2468-76. doi: 10.1007/s11095-012-0776-7. Epub 2012 May 30.
2
Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.正电子发射断层扫描研究啮齿动物脑中中枢神经系统药物的结合及P-糖蛋白功能。
Mol Imaging Biol. 2005 Jan-Feb;7(1):37-44. doi: 10.1007/s11307-005-0951-x.
3
Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain Kinetics.血脑屏障中 P-糖蛋白的抑制或缺失对(18)F-2-氟-2-脱氧-D-葡萄糖((18)F-FDG)脑动力学的影响。
AAPS J. 2015 May;17(3):652-9. doi: 10.1208/s12248-015-9739-3. Epub 2015 Feb 26.
4
Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.成像环孢素A和双嘧达莫对血脑屏障处P-糖蛋白(ABCB1)功能的影响:一项在非人类灵长类动物中进行的[(11)C]-N-去甲基洛哌丁胺PET研究。
Eur J Pharm Sci. 2016 Aug 25;91:98-104. doi: 10.1016/j.ejps.2016.06.005. Epub 2016 Jun 7.
5
(18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.(18)F-FCWAY,一种5-羟色胺1A受体放射性配体,是人类血脑屏障处外排转运的底物。
Neuroimage. 2016 Sep;138:134-140. doi: 10.1016/j.neuroimage.2016.05.045. Epub 2016 May 19.
6
Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.环孢素,一种P-糖蛋白调节剂,可增加大鼠脑和外周组织中[18F]MPPF的摄取:微型正电子发射断层扫描和离体研究。
Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2256-66. doi: 10.1007/s00259-008-0832-z. Epub 2008 Jul 5.
7
PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.使用[(18)F] -吉非替尼进行PET-CT成像,以测量小鼠血脑屏障处Abcb1a/1b(P-糖蛋白)和Abcg2(Bcrp1)介导的药物相互作用。
Nucl Med Biol. 2015 Nov;42(11):833-41. doi: 10.1016/j.nucmedbio.2015.07.004. Epub 2015 Jul 15.
8
Pharmacokinetic Modeling of [F]MC225 for Quantification of the P-Glycoprotein Function at the Blood-Brain Barrier in Non-Human Primates with PET.利用 PET 对非人类灵长类动物血脑屏障 P-糖蛋白功能进行定量的 [F]MC225 的药代动力学建模。
Mol Pharm. 2020 Sep 8;17(9):3477-3486. doi: 10.1021/acs.molpharmaceut.0c00514. Epub 2020 Aug 17.
9
Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.大鼠脑内 5-HT1A 拮抗剂[18F]-MPPF 的摄取和结合:新型 P-糖蛋白抑制剂塔里奎达的影响。
Neuroimage. 2010 Jan 15;49(2):1406-15. doi: 10.1016/j.neuroimage.2009.09.048. Epub 2009 Sep 28.
10
Evaluation of P-glycoprotein (abcb1a/b) modulation of [(18)F]fallypride in MicroPET imaging studies.在小动物正电子发射断层显像(MicroPET)成像研究中评估P-糖蛋白(abcb1a/b)对[18F]氟哌利多的调节作用。
Neuropharmacology. 2014 Sep;84:152-8. doi: 10.1016/j.neuropharm.2013.04.062. Epub 2013 Aug 29.

引用本文的文献

1
Imaging the impact of sex and age on OATP function in humans: Consequences for whole-body pharmacokinetics and liver exposure.成像性别和年龄对人体有机阴离子转运多肽(OATP)功能的影响:对全身药代动力学和肝脏暴露的影响。
Acta Pharm Sin B. 2025 May;15(5):2736-2745. doi: 10.1016/j.apsb.2025.03.030. Epub 2025 Mar 17.
2
Discovery and evaluation of a novel F-labeled vasopressin 1a receptor PET ligand with peripheral binding specificity.一种具有外周结合特异性的新型F标记血管加压素1a受体PET配体的发现与评估。
Acta Pharm Sin B. 2024 Sep;14(9):4014-4027. doi: 10.1016/j.apsb.2024.05.033. Epub 2024 Jun 3.
3
Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and Challenges.

本文引用的文献

1
Cerebral expression of drug transporters in epilepsy.脑内药物转运体在癫痫中的表达。
Adv Drug Deliv Rev. 2012 Jul;64(10):919-29. doi: 10.1016/j.addr.2011.11.008. Epub 2011 Nov 29.
2
Blood-brain barrier P-glycoprotein function in neurodegenerative disease.血脑屏障 P-糖蛋白在神经退行性疾病中的功能。
Curr Pharm Des. 2011;17(26):2771-7. doi: 10.2174/138161211797440122.
3
Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.血脑屏障上的 ATP 结合盒转运蛋白对阿片类物质的转运:对神经精神药理学的影响。
三磷酸腺苷结合盒(ABC)转运蛋白的心脏正电子发射断层显像(PET):机遇与挑战
Pharmaceuticals (Basel). 2023 Dec 11;16(12):1715. doi: 10.3390/ph16121715.
4
Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?血脑屏障 P-糖蛋白部分抑制对 PET 配体的比较脆弱性:选择标准?
J Cereb Blood Flow Metab. 2022 Jan;42(1):175-185. doi: 10.1177/0271678X211045444. Epub 2021 Sep 9.
5
The pharmacokinetics of [F]UCB-H revisited in the healthy non-human primate brain.[F]UCB-H在健康非人灵长类动物大脑中的药代动力学再研究。
EJNMMI Res. 2021 Apr 7;11(1):36. doi: 10.1186/s13550-021-00777-8.
6
Quantitative Rodent Brain Receptor Imaging.定量啮齿动物脑受体成像。
Mol Imaging Biol. 2020 Apr;22(2):223-244. doi: 10.1007/s11307-019-01368-9.
7
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate C-Metoclopramide Assessed with PET Imaging in Humans.利用 PET 成像在人体中评估 P-糖蛋白功能对弱底物 C-美托洛嗪脑动力学的影响。
J Nucl Med. 2019 Jul;60(7):985-991. doi: 10.2967/jnumed.118.219972. Epub 2019 Jan 10.
8
Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.用于脑成像的可逆结合正电子发射断层显像(PET)放射性配体开发中的注意事项。
Curr Med Chem. 2016;23(18):1818-69. doi: 10.2174/0929867323666160418114826.
9
P-Glycoprotein, not BCRP, Limits the Brain Uptake of [(18)F]Mefway in Rodent Brain.P-糖蛋白而非乳腺癌耐药蛋白限制了啮齿动物脑中[(18)F]美法韦的脑摄取。
Mol Imaging Biol. 2016 Apr;18(2):267-73. doi: 10.1007/s11307-015-0883-z.
10
Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain Kinetics.血脑屏障中 P-糖蛋白的抑制或缺失对(18)F-2-氟-2-脱氧-D-葡萄糖((18)F-FDG)脑动力学的影响。
AAPS J. 2015 May;17(3):652-9. doi: 10.1208/s12248-015-9739-3. Epub 2015 Feb 26.
Curr Pharm Des. 2011;17(26):2829-42. doi: 10.2174/138161211797440203.
4
In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.人 P 糖蛋白对卡马西平、奥卡西平、艾司利卡西平及其活性代谢物的体外转运特征。
Epilepsia. 2011 Oct;52(10):1894-904. doi: 10.1111/j.1528-1167.2011.03140.x. Epub 2011 Jun 21.
5
In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate.体内[F-18]MEFWAY 的动力学:与非人类灵长类动物中[C-11]WAY100635 和[F-18]MPPF 的比较。
Synapse. 2011 Jul;65(7):592-600. doi: 10.1002/syn.20878. Epub 2010 Dec 8.
6
Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions.底物和物种依赖性对 P-糖蛋白介导的转运的抑制:对预测体内药物相互作用的影响。
J Pharm Sci. 2011 Aug;100(8):3055-3061. doi: 10.1002/jps.22566. Epub 2011 Apr 11.
7
Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.人 P-糖蛋白(ABCB1)和乳腺癌耐药蛋白(ABCG2)对选定的 PET 放射性示踪剂的转运:体外筛选。
J Nucl Med. 2011 Mar;52(3):415-23. doi: 10.2967/jnumed.110.079608. Epub 2011 Feb 14.
8
Avoiding barriers to PET radioligand development: cellular assays of brain efflux transporters.规避正电子发射断层扫描(PET)放射性配体研发的障碍:脑外排转运体的细胞分析
J Nucl Med. 2011 Mar;52(3):338-40. doi: 10.2967/jnumed.110.081125. Epub 2011 Feb 14.
9
Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy.P-糖蛋白介导的海马区药物耐药性的影像学研究:在颞叶癫痫慢性大鼠模型中的概念验证。
Epilepsia. 2010 Sep;51(9):1780-90. doi: 10.1111/j.1528-1167.2010.02671.x. Epub 2010 Jul 14.
10
Membrane transporters in drug development.药物开发中的膜转运体。
Nat Rev Drug Discov. 2010 Mar;9(3):215-36. doi: 10.1038/nrd3028.